Abstract
Siponimod for multiple sclerosis.
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1002/14651858.cd013647.pub2
Publication Date: Nov 16, 2021 | |
Citations: 6 |
Siponimod for multiple sclerosis.
Join us for a 30 min session where you can share your feedback and ask us any queries you have